EDGAR Filing Documents for 0001193125-09-256411

Form 8-K - Current report:

SEC Accession No. 0001193125-09-256411

Filing Date

2009-12-21

Accepted

2009-12-21 08:23:04

Documents

Period of Report

2009-12-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	35318
2	ARTICLES OF AMENDMENT TO 2002 RESTATED ARTICLES OF INCORPORATION	dex31.htm	EX-3.1	56536
3	SERIES G CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT	dex101.htm	EX-10.1	157655
4	REGISTRATION RIGHTS AGREEMENT	dex102.htm	EX-10.2	90289
5	PRESS RELEASE	dex991.htm	EX-99.1	9163
6	GRAPHIC	g32693g29k90.jpg	GRAPHIC	4698
	Complete submission text file	0001193125-09-256411.txt		357660

Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062

Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001

BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)